SCHEMBL21730744

SCHEMBL21730744

O=C1COC2CCN(C(=O)N3CCN(Cc4ccc(C(F)(F)F)cc4)CC3)C[C@H]2N1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 10/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21723273 1.00 MGLL (0.63) MGLL
SCHEMBL21723274 1.00 MGLL (0.63) MGLL
SCHEMBL22488599 0.88 MGLL (0.59) MGLL
SCHEMBL23149203 0.88 MGLL (0.59) MGLL
SCHEMBL27275912 0.88 MGLL (0.59) MGLL
SCHEMBL22488617 0.88 MGLL (0.66) MGLL
SCHEMBL21730850 0.88 MGLL (0.66) MGLL
SCHEMBL23148866 0.88 MGLL (0.66) MGLL
SCHEMBL21730851 0.88 MGLL (0.66) MGLL
SCHEMBL22462763 0.88 MGLL (0.66) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837263-B1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS HOFFMANN LA ROCHE (CH) 2024-07-03 — — EP disclosed
WO-2020035424-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2020-02-20 — — WO disclosed
WO-2020035425-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2020-02-20 — — WO disclosed
Send feedback